An ‘adverse finding’ has reportedly been found in one of Conor Benn‘s VADA test ahead of his huge showdown with Chris Eubank Jr this weekend.
The news was first broke by Riath Al-Samarrai of MailSport, who has reported that the banned substance in question is clomifene, a drug primarily used to treat infertility in women but can also increase the production of testosterone in the male body.
Eubank Jr is believed to still be in favour of the bout going ahead this weekend at London’s O2 Arena, with the fight set to be broadcast live on DAZN pay-per-view.
Matchroom Boxing and Wasserman Boxing, who are both co-promoters of the event, released a joint statement shortly after the news broke on Wednesday afternoon insisting that the fight will still take place in the capital this weekend. “We have been made aware that a random anti-doping test for Conor Benn conducted by the Voluntary Anti-Doping Association returned an adverse analytical finding for trace amounts of a fertility drug. The B sample has yet to be tested, meaning that no rule violation has been confirmed. Indeed, Mr Benn has not been charged with any rule violation, he is not suspended, and he remains free to fight.”
The statement continues, “Mr Benn has since passed a doping control test conducted by the UK Anti-Doping Agency, the anti-doping authority to which the British Board of Boxing Control has delegated its doping control testing for the bout. Mr Benn has passed all doping control tests conducted by UKAD.
“Both fighters have taken medical and legal advice, are aware of all relevant information, and wish to proceed with the bout this Saturday.”
Read the full MailSport article here.